期刊文献+

血清PCSK9水平对老年非酒精性脂肪性肝病动脉粥样硬化程度及预后的判断价值

Predictive value of serum PCSK9 level for the degree of atherosclerosis in elderly patients with nonalcoholic fatty liver disease
下载PDF
导出
摘要 目的探讨老年血清前蛋白转化酶枯草溶菌素9(PCSK9)水平对非酒精性脂肪性肝病(NAFLD)动脉粥样硬化程度及预后的判断价值。方法纳入2020年4月至2021年4月在唐山市中医医院、唐山市人工医院就诊的NAFLD患者254例,根据Gensini积分四分位法分为轻度组(0~24分)84例,中度组(25~53分)86例,重度组(≥54分)84例。根据NAFLD患者是否发生主要心脑血管事件(MACCE)分为MACCE组30例与无MACCE组224例。对比各组间的临床资料,Pearson分析Gensini积分与PCSK9的相关性,Cox分析发生MACCE风险的危险因素,ROC曲线分析PCSK9对老年NAFLD患者发生MACCE的预测价值。结果轻度组hs-CRP、PCSK9、TG、LDL-C、Lp(a)分别为5.79(4.17,7.81)mg/L、(329.17±50.26)ng/mL、(1.47±0.33)mmol/L、(2.69±0.52)mmol/L、(0.52±0.12)mg/L,中度组分别为6.22(4.61,7.58)mg/L、(416.33±55.92)ng/mL、(1.65±0.36)mmol/L、(2.87±0.35)mmol/L、(0.63±0.09)mg/L,重度组分别为7.85(6.21,9.11)mg/L、(498.55±61.28)ng/mL、(1.86±0.24)mmol/L、(3.95±0.48)mmol/L、(0.70±0.11)mg/L,依次升高;HDL-C在轻度组、中度组、重度组依次降低,分别为(1.46±0.25)mmol/L、(1.20±0.22)mmol/L、(1.06±0.27)mmol/L,差异均有统计学意义(P<0.05);PCSK9与Gensini呈正相关(r=0.657,P<0.01)。MACCE组的年龄为(72.1±5.5)岁、Gensini积分为(86.27±5.03)分、PCSK9为(489.71±63.05)ng/mL、LDL-C为(2.88±0.79)mmol/L,较无MACCE组的(68.6±3.4)岁、(61.09±4.52)分、(356.03±51.19)ng/mL、(2.52±0.77)mmol/L更高,差异有统计学意义(P<0.05)。多因素Cox风险回归分析结果显示,Gensini积分(HR=1.018,95%CI:1.006~1.029)、PCSK9(HR=1.147,95%CI:1.038~1.287)是发生MACCE的独立危险因素。PCSK9预测MACCE发生的AUC为0.724,灵敏度为68.25%,特异度为75.92%。结论血清PCSK9与老年NAFLD患者Gensini积分呈正相关,可作为患者发生MACCE的预测指标。 Objective To investigate the predictive value of serum proprotein convertase subtilisin 9(PCSK9)level in elderly patients with nonalcoholic fatty liver disease(NAFLD)in predicting the degree of atherosclerosis and prognosis.Methods From April 2020 to April 2021,254 NAFLD patients who were treated in Tangshan Traditional Chinese Medicine Hospital and Tangshan Artificial Hospital were divided into three groups according to the quartiles of Gensini score:Group 1(Gensini score≤24,n=84);Group 2(24<Gensini score≤53,n=86)and Group 3(Gensini score>53,n=84).According to whether NAFLD patients had major cardiovascular and cerebrovascular events(MACCE),they were divided into the MACCE group(n=30)and non-MACCE group(n=224).The clinical data among the groups were compared.The relationship between Gensini score and PCSK9 was analyzed by Pearson correlation analysis.The risk factors of MACCE risk were analyzed by Cox risk model,and the predictive value of PCSK9 on the occurrence of MACCE in elderly patients with NAFLD was analyzed by ROC curve.Results hs-CRP,PCSK9,TG,LDL-C,and Lp(a)increased in Group 1[5.79(4.17,7.81)mg/L,(329.17±50.26)ng/mL,(1.47±0.33)mmol/L,(2.69±0.52)mmol/L,(0.52±0.12)mg/L],Group 2[6.22(4.61,7.58)mg/L,(416.33±55.92)ng/mL,(1.65±0.36)mmol/L,(2.87±0.35)mmol/L,(0.63±0.09)mg/L],and Group 3[7.85(6.21,9.11)mg/L,(498.55±61.28)ng/mL,(1.86±0.24)mmol/L,(3.95±0.48)mmol/L,(0.70±0.11)mg/L]contrary to HDL-C[(1.46±0.25)mmol/L,(1.20±0.22)mmol/L,(1.06±0.27)mmol/L]].There were significant differences between the three groups(P<0.05);PCSK9 was positively correlated with Gensini score(r=0.657,P=0.000).The age,Gensini score,PCSK9 and LDL-C of the MACCE group[[(72.12±5.54)years,(86.27±5.03)points,(489.71±63.05)ng/mL,(2.88±0.79)mmol/L]were significantly higher than those of the non-MACCE group[(68.63±3.35)years,(61.09±4.52)points,(356.03±51.19)ng/mL,(2.52±0.77)mmol/L,all P<0.05].Multivariate Cox risk regression analysis showed that Gensini score and PCSK9 were independent risk factors for the risk of MACCE(P<0.05).The AUC of PCSK9 for predicting the occurrence of MACCE was 0.724,the sensitivity was 68.25%,and the specificity was 75.92%.Conclusion Serum PCSK9 is positively correlated with Gensini score in elderly patients with NAFLD,which could be used as a predictor of MACCE in patients.
作者 李少君 李静 于佳新 LI Shao-jun;LI Jing;YU Jia-xin(Department of Laboratory,Tangshan Hospital of Traditional Chinese Medicine,Hebei 063000,China;Internal Medicine-Cardiovascular Department,Tangshan Workers Hospital,Hebei 063000,China)
出处 《肝脏》 2023年第4期479-482,499,共5页 Chinese Hepatology
基金 河北省医学科学研究课题计划(20210519)。
关键词 老年人 非酒精性脂肪性肝病 动脉粥样硬化 循环前蛋白转化酶枯草溶菌素9 Aged Nonalcoholic fatty liver disease Atherosclerosis Circulating proprotein convertase subtilisin 9
  • 相关文献

参考文献8

二级参考文献49

  • 1危当恒,王贵学,王佐,刘录山,吕运成,唐朝克.基质细胞衍生因子1对低密度脂蛋白诱导单核—内皮细胞粘附的影响[J].中国动脉硬化杂志,2006,14(5):387-390. 被引量:10
  • 2HAN D,MA J,ZHANG X,et al.Correlation of PCSK9 gene polymorphism with cerebral ischemic stroke in Xinjiang Han and Uygur populations[J].Med Sci Monit,2014,20:1758-1767.
  • 3HERBERT B,PATEL D,WADDINGTON S N,et al.Increased secretion of lipoproteins in transgenic mice expressing human D374Y PCSK9under physiological genetic control[J].Arterioscler Thromb Vasc Biol,2010,30:1333-1339.
  • 4WERNER C,HOFFMANN M M,WINKLER K,et al.Risk prediction with proprotein convertase subtilisin/kexin type 9(PCSK9)in patients with stable coronary disease on statin treatment[J].Vascul Pharmacol,2014,62:94-102.
  • 5ALMONTASHIRI N A M,VILMUNDARSON R O,GHASEMZADEH N,et al.Plasma PCSK9 Levels Are Elevated with Acute Myocardial Infarction in Two Independent Retrospective Angiographic Studies[J].PLoS ONE,2014,9:e106294.
  • 6LEE C J,LEE Y H,PARK S W,et al.Association of serum proprotein convertase subtilisin/kexin type 9with carotid intima media thickness in hypertensive subjects[J].Metabolism,2013,62:845-850.
  • 7LI S,GUO Y L,XU R X,et al.Plasma PCSK9levels are associated with the severity of coronary stenosis in patients with atherosclerosis[J].Int J Cardiol,2014,174:863-864.
  • 8CUI Q,JU X,YANG T,et al.Serum PCSK9is associated with multiple metabolic factors in a large Han Chinese population[J].Atherosclerosis,2010,213:632-636.
  • 9TAVORI H,FAN D,BLAKEMORE J L,et al.Serum proprotein convertase subtilisin/kexin type 9and cell surface low-density lipoprotein receptor:evidence for a reciprocal regulation[J].Circulation,2013,127:2403-2413.
  • 10LEVY E,OUADDA A B D,SPAHIS S,et al.PC-SK9plays a significant role in cholesterol homeostasis and lipid transport in intestinal epithelial cells[J].Atherosclerosis,2013,227:297-306.

共引文献1703

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部